Gilead Sales Reps To Promote Virco HIV Resistance Test Services
This article was originally published in The Gray Sheet
Executive Summary
Gilead Sciences will leverage its 60-rep U.S. sales force under a collaborative promotional and educational effort with Virco to increase awareness among physicians treating patients with HIV of Virco's phenotypic and genotypic HIV resistance monitoring assays, the firms announced March 7.